Short communication Break Through Infection Following Covid 19 Vaccination Among Health Care Workers In South India .

JAYAKRISHNAN THAYYIL; ARDRA MERIN GEORGE

doi:10.22159/ajpcr.2021.v14i10.42878

Authors

JAYAKRISHNAN THAYYIL Department of Community Medicine, Government Medical College, Calicut, Kerala, India.
ARDRA MERIN GEORGE Department of Community Medicine, Government Medical College, Calicut, Kerala, India.

DOI:

https://doi.org/10.22159/ajpcr.2021.v14i10.42878

Keywords:

Covishield vaccine, Covaxin, Covid 19 Vaccine, Break through infection, South India

Abstract

We here reported Covid 19 break through infections among HCWs following any of the above vaccines in our institution .Breakthrough infections were defined as “the detection of SARS-Cov2RNA or antigen in a respiratory specimen collected from a person >14 days after they have completed two recommend doses of Covid 19 vaccines”. Total we have received 737 responses from our HCWs ,out of which 677 (92%) were vaccinated. Majority of them 642 (95%) received Covishield and rest 35 (5%) received Covaxin. Out of this 89 persons have developed any symptoms tested positive fourteen days after receiving full course vaccines.

Downloads

Download data is not yet available.

References

Covid-19 vaccines, Operational Guidelines. Ministry of Health and Family Welfare. Government of India; 2020. Available from: https:// www.mohfw.gov.in/pdf/COVID19Vaccine.

Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, et al, The COVAXIN Study Group. Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): A double-blind, randomized, controlled phase 3 trial. MedRxiv 2021. DOI: https://doi.org/10.1101/2021.06.30.21259439.

Emary KR, Golubchik T, Aley PK. Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): An exploratory analysis of a randomized controlled trial. Lancet 2021;397:1351-62.

Tyagi K, Ghosh A, Nair D, Dutta K, Bhandari P, Ansari I, et al. Breakthrough COVID-19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India. Diabetes Metab Syndr 2021;15:1007-8.

Victor PJ, Mathews KP, Paul H, Mammen JJ, Murugesan M. Protective effect of COVID-19 vaccine among health care workers during the second wave of the pandemic in India. Mayo Clin Proc 2021;96:2493-4.

Rana K, Mohindra R, Pinnaka L. Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med 2021;385:2.

Keehner J, Horton LE, Pfeffer MA, Longhurst CA, Schooley RT, Currier JS, et al. SARS-CoV-2 infection after vaccination in health care workers in California. N Engl J Med 2021;384:1774-5.